HBV DNA in serum of HBsAg-negative, anti-HBc-positive blood donors

被引：2
|
作者：
Yotsuyanagi, H [1 ]
Yasuda, K
Iino, S
Moriya, K
Shintani, Y
Fujimie, H
Tsutsumi, T
Kimura, S
Koike, K
Norjiri, N
Juji, T
Hoshino, H
Hino, K
机构：
[1] St Marianna Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1130033, Japan
[3] Japanese Red Cross Cent Blood Ctr, Tokyo, Japan
[4] Hepatitis Res Inst, Tokyo, Japan
来源：
TRANSFUSION | 2002年 / 42卷 / 12期
关键词：
D O I：
10.1046/j.1537-2995.2002.00298_3.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1616 / 1617
页数：2
相关论文
共 50 条
  • [41] Rituximab and hepatitis B reactivation in HBsAg-negative/anti-HBc-positive kidney transplant recipients (vol 32, pg 722, 2017)
    Lee, Juhan
    Park, Jun Yong
    Huh, Kyu Ha
    Kim, Beom Seok
    Kim, Myoung Soo
    Kim, Soon Il
    Ahn, Sang Hoon
    Kim, Yu Seun
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (05) : 906 - 906
  • [42] HEPATITIS B VIRUS VARIANTS IN HBSAG-NEGATIVE, ANTE-HBC POSITIVE BLOOD DONORS: INFECTIVITY, PATHOGENICITY AND VARIABILITY
    Gerlich, W. H.
    Wienzek, S.
    Wend, U. C.
    Dickmeiss, E.
    Saniewski, M.
    Chudy, M.
    Glebe, D.
    Lattermann, A.
    Schuettler, C. G.
    Harritshoj, L.
    Ullum, H.
    Willems, W. R.
    [J]. VOX SANGUINIS, 2010, 99 : 22 - 22
  • [43] Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy
    Kuhns, MC
    Kleinman, SH
    McNamara, AL
    Rawal, B
    Glynn, S
    Busch, MP
    [J]. TRANSFUSION, 2004, 44 (09) : 1332 - +
  • [44] Anti HBc titres and HBV DNA in Indian blood donors
    [J]. 中国输血杂志, 2001, (S1) : 332 - 332
  • [45] Low prevalence of HBV DNA in the liver allograft from anti-HBc-positive donors: a single-center experience
    Pan, Jen-Jung
    Oh, Seh-Hoon
    Soldevila-Pico, Consuelo
    Nelson, David R.
    Liu, Chen
    [J]. CLINICAL TRANSPLANTATION, 2011, 25 (01) : 164 - 170
  • [46] Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?
    Loss, GE
    Mason, AL
    Nair, S
    Blazek, J
    Farr, G
    Guo, LS
    Cohen, AJ
    Eason, JD
    [J]. LIVER TRANSPLANTATION, 2003, 9 (12) : 1258 - 1264
  • [47] HBV DNA detection in HBsAg negative/anti-core positive Italian first time blood donors
    Velati, C.
    Romanò, L.
    Fomiatti, L.
    Cambiè, G.
    Zanetti, A.
    [J]. VOX SANGUINIS, 2006, 91 : 66 - 66
  • [48] A follow up study on detection of HBV DNA positive and HBsAg negative blood donors
    Ye, X. L.
    [J]. VOX SANGUINIS, 2008, 95 : 23 - 23
  • [49] Serological and molecular characteristics of HBV DNA positive/HBsAg negative blood donors.
    Brojer, E.
    Letowska, M.
    Liszewski, G.
    Grabarczyk, P.
    Mikulska, M.
    [J]. VOX SANGUINIS, 2006, 91 : 76 - 76
  • [50] Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor
    Cerva, C.
    Colagrossi, L.
    Maffongelli, G.
    Salpini, R.
    Di Carlo, D.
    Malagnino, V.
    Battisti, A.
    Ricciardi, A.
    Pollicita, M.
    Bianchi, A.
    Picardi, A.
    Cudillo, L.
    Cerretti, R.
    De Angelis, G.
    Cantonetti, M.
    Andreoni, M.
    Perno, C. F.
    Arcese, W.
    Svicher, V.
    Sarmati, L.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (11) : 946.e1 - 946.e8
12345